Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Accumulated Depreciation & Amortization (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Accumulated Depreciation & Amortization for 2 consecutive years, with $838000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Accumulated Depreciation & Amortization changed N/A to $838000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $838000.0, a N/A change, with the full-year FY2022 number at $3.2 million, changed N/A from a year prior.
  • Accumulated Depreciation & Amortization was $838000.0 for Q3 2023 at LENZ Therapeutics, down from $3.2 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $3.2 million in Q4 2022 to a low of $838000.0 in Q3 2023.